We have previously reported that an X-linked recessive form of chronic idiopathic intestinal pseudo-obstruction (CIIPX) maps to Xq28. To select candidate genes for the disease, we analyzed the expression in murine fetal brain and intestine of 56 genes from the critical region. We selected and sequenced seven genes and found that one affected male from a large CIIPX-affected kindred bears a 2-bp deletion in exon 2 of the FLNA gene that is present at the heterozygous state in the carrier females of the family. The frameshift mutation is located between two close methionines at the filamin N terminus and is predicted to produce a protein truncated shortly after the first predicted methionine. Loss-of-function FLNA mutations have been associated with X-linked dominant nodular ventricular heterotopia (PVNH), a central nervous system (CNS) migration defect that presents with seizures in females and lethality in males. Notably, the affected male bearing the FLNA deletion had signs of CNS involvement and potentially has PVNH. To understand how the severe frameshift mutation we found can explain the CIIPX phenotype and its X-linked recessive inheritance, we transiently expressed both the wild-type and mutant filamin in cell culture and found that filamin translation can start from either of the two initial methionines in these conditions. Therefore, translation of a normal shorter filamin can occur in vitro from the second methionine downstream of the 2-bp insertion we found. We confirmed this, demonstrating that the filamin protein is present in the patient's lymphoblastoid cell line that shows abnormal cytoskeletal actin organization compared with normal lymphoblasts. We conclude that the filamin N terminal region between the initial two methionines is crucial for proper enteric neuron development.
Chronic idiopathic intestinal pseudo-obstruction (CIIP [MIM %300048]
) is a clinical syndrome caused by a heterogeneous group of enteric neuromuscular diseases that result in a severe abnormality of gastrointestinal motility. 1 CIIP may present at any age and is diagnosed by radiological, surgical, or manometric evidence of abnormal bowel motility causing intestinal obstruction in the absence of any mechanical occlusion. 1 CIIP is an uncommon, often fatal, syndrome in infancy, which may occur because of primary intrinsic visceral neuromuscular disorders or secondary to a variety of conditions, such as drug toxicity, ischemia, inflammatory or autoimmune diseases, myopathies, or viral infections (e.g., Epstein-Barr or cytomegalovirus [CMV] ). 1 Primary forms of CIIP are neurogenic (28%), myopathic (36%), or unclassifiable (36%). 2 Neuropathic abnormalities of enteric innervation cause neurogenic CIIP and may be quantitative (hypo-, hyper-, and aganglionosis) or qualitative in nature. 2 In Hirschsprung disease (HSCR [MIM #142623]), the most common neuronal CIIP, lack of migration of enteric ganglion cells during development results in aganglionosis along gastrointestinal segments of variable length. 2 In other cases, migration of enteric neurons is not affected, but enteric ganglia and nerve fibers show qualitative abnormalities, suggesting the presence of a differentiation defect. This may be the case for the patients described by Tanner 3 -affected by a short intestine, malrotation, and hypertrophic pyloric stenosis-who were reported to have absence of argyrophilic neurons in the myenteric plexus. 3 The condition was thought to be inherited as an autosomal recessive trait. 3 More recently, we reported an Italian family with 10 affected males in 4 generations, all related through healthy females; of the 10, 9 died in the first months of life. Two affected subjects (IV-1 and IV-5) in the last generation ( fig. 1A ) had severe CIIP associated with a short small intestine, malrotation, and hypertrophic pyloric stenosis. 4 Subject IV-1 survived repeated surgery and is still alive. Histological analysis of full-thickness ileal and colonic biopsies of samples from the two subjects evidenced abnormal neurons in the myenteric and submucosal plexuses. 4 Like the patients described by Tanner et al., 3 there were abnormalities of argyrophilic neurons. In our study family, the condition appeared to be inherited with a clear X-linked recessive pattern-that is, X-linked chronic idiopathic intestinal pseudo-obstruction (CIIPX)-and we mapped the disease locus to Xq28 between DXS15 and DXYS154. 4 There was an additional report by FitzPatrick et al. 5 about neurogenic CIIP with patent ductus arteriosus and large platelet thrombocytopenia, apparently inherited in an X-linked recessive manner. By April 2003, 63 genes were annotated in the CIIPX critical region (Human Genome Browser Gateway). We analyzed their expression in fetal murine gut and brain, to select candidate CIIPX genes, and we found a frameshift mutation in the filamin A gene (FLNA [MIM ϩ300017]) that was associated with CIIPX in the Italian kindred.
Material and Methods

Clinical History
The index patient (IV-1), second cousin to subject IV-5, is a male and the first offspring of healthy, nonconsanguineous parents ( fig. 1A ). He was born at term after an uneventful pregnancy. On the 3rd d of life, he presented with bilious vomiting, and laparatomy showed a short small bowel with intestinal malrotation, pyloric hypertrophy, and an ileal volvulus. Fifteen days later, he required additional surgery for intestinal obstruction, and an ileostomy was raised. Histological examination of full-thickness ileal and colonic biopsies showed abnormal argyrophilic neurons in the myenteric plexus, as well as nerve fibers in the lamina propria in the colon. 4 Findings similar to the myenteric plexus were present in the submucosal plexus. At age 3 mo, continuity of his bowel was restored with an ileoileal anastomosis, but the bowel once again became obstructed. Manometric studies suggested a neuropathic disorder of his gut. A further ileostomy was raised, and full-thickness material was taken for further histology. At age 3 years, a Lester-type ileorectal anastomosis was performed to restore bowel continuity. In addition to the severe CIIP, by age 7 years, an asymmetrical spastic diplegia with impairment of fine finger movements also became apparent. Magnetic resonance imaging (MRI) of his brain showed an abnormal intermediate signal in the peritrigonal white matter. The patient and two carrier females in the family declined to undergo additional brain MRI after the identification of the FLNA mutation. The patient required lengthening operations for both Achilles tendons. He also had seizures: the first time after surgery during his 1st mo of life, then again at ages 8 and 18 years. Since the last episode, he has received carbamazepine treatment. He continues to require supplemental parenteral nutrition to maintain good health.
The second patient (IV-5) was a male, the third offspring of healthy, unrelated parents ( fig. 1A ). His older brother and sister have no gastrointestinal disorders and are completely well. He was born at term, weighed 4.2 kg, and measured 52 cm in length. On his 1st d of life, he had abdominal distension and bilious vomiting. Laparotomy demonstrated a small-intestinal malrotation with CIIP. Because of ongoing subocclusive symptoms, two intestinal resections were performed during the following weeks. He required total parenteral nutrition and an additional operation with ileoileal anastomosis. Intestinal histology of the ileum showed abnormalities of the myenteric and submucosal neurons similar to those of subject IV-1. Subject IV-5 died shortly after surgery, at age 8 mo.
Genomic DNA Extraction and PCR Amplification and Sequencing
Genomic DNA was isolated from peripheral-whole-blood lymphocytes and from paraffin-embedded sections by use of standard protocols (Qiagen Italy) or as described elsewhere. 4 The complete coding sequence of seven genes selected for direct sequencing, including the exon-intron boundaries, was amplified by PCR with Taq Gold DNA Polymerase (Roche). These genes are (from X chromosome centromere to telomere): ZNF275, ATP2B3 (MIM *300014), DUSP9 (MIM *300134), SLC6A8 (MIM *300036), ABCD1 (MIM *300371), L1CAM (MIM *308840), and FLNA. PCR was performed as follows: 35 cycles with 50 ng of genomic DNA at 94ЊC for 1 min, at the appropriate primer annealing temperature for 1 min, and at 72ЊC for 1 min. Primers and reaction conditions for PCR amplification are available on request.
Amplicons were screened for mutations by direct sequencing with an ABI PRISM Big Dye terminator cycle sequencing kit, and the reactions were analyzed with an ABI PRISM 3100 genetic analyzer (Applied Biosystems). The sequenced exon and intronexon boundaries were compared with consensus sequences obtained from the National Center for Biotechnology Information Database with use of standard software for DNA sequencing analysis (Autoassembler v. 2.1 [Applied Biosystems]). Sixty-six females and 32 males from the general Italian population were used as controls, for a total of 164 X chromosomes. 
RT-PCR Analysis of Gene Expression from the CIIPX Critical Region
Total RNA from C57BL/6 mice (Harlan Italy), from embryonic day-18 (E18) mouse brain or gut, from 5-wk-old mouse gut, and from V-1 individual lymphoblastoid cells was extracted using the Trizol reagent (Invitrogen Italy) according to the manufacturer's instructions. After DNAse treatment, 5 mg of total RNA was used as a template for cDNA synthesis, with use of random primers and SuperScript III (Invitrogen Italy). Subsequently, PCR amplification was performed using oligonucleotides specific for each of the 63 genes included in the CIIPX critical region and was designed in the region of homology between human and murine RNAs with use of the Oligo 4.0 software (National Biosciences). PCR was performed using Taq Gold DNA polymerase (Roche), with 35 cycles at 94ЊC for 1 min, at the appropriate primer annealing temperature for 1 min, and at 72ЊC for 1 min. Primer sequences and reaction conditions for each gene are available on request.
Generation of the Plasmid Constructs Expressing Filamin A NH 2 Terminus
We generated two plasmids that express the first N-terminal 124 aa of FLNA by fusing to a hemoagglutinin tag (HA) under the transcriptional control of the ubiquitous CMV promoter. In plasmid 1, the wild-type FLNA sequence was included, whereas, in plasmid 2, the FLNA sequence corresponding to c.65-66delAC was introduced. To do so, FLNA exon 2 sequence from the initial ATG codon to genome position 3688 was amplified from control and the patient's genomic DNA, with use of primers NotI, 5 -ATG AGT AGC TCC CAC TCT CGG GCG GGC CAG-3 , and BamHI-TTA-HA epitope tag, 5 -GAT GGA CAC CAG TTT GAT GCT CTC GCG GT-3 . The amplification was performed with Pfu DNA Polymerase (Promega Italy). The PCR product was inserted into PCR 2.1-TOPO plasmid (Invitrogen) and then was digested with NotI and BamHI restriction enzymes. The corresponding fragments from control and patient were then cloned into pAAV2.1-CMV-EGFP by removing the EGFP-coding sequence, to obtain plasmid 1 and plasmid 2, respectively.
Transfection of HEK 293 Cells with Constructs Expressing Filamin A and Western Blot Analysis
Human embryonic kidney (HEK) 293 cells were plated in 6-well plates containing cells/well. After 24 h, the cells were Membranes were incubated at room temperature for 1.5 h in blocking buffer containing 1# TBS and 0.05% Tween 20 with 5% dried nonfat milk and then were probed with an anti-HA antibody (Sigma-Aldrich) for 2 h at room temperature. This was followed by incubation with a peroxidaseconjugated secondary anti-rabbit IgG for 1 h at room temperature. Signals were detected by chemoluminescence with the Pico Enhanced Chemiluminescence Kit (Pierce Chemical). A prestained molecular-weight ladder (Fermentas) was used to determine protein size.
Western Blot Analysis of Filamin A Expression in Patient Lymphoblasts
Lymphoblasts from patient IV-1 and from two control individuals were grown in Roswell Park Memorial Institute PMI 1640 plus medium with 20% fetal bovine serum (FBS) in 5% CO 2 at 37ЊC, were harvested, precipitated, and lysed with Lysis buffer (50 mM NaCl, 25 mM Tris [pH 8.0], 0.5% NP40, 0.1% SDS, 1 mM protease inhibitors [Roche] , and 1 mM PMSF) on ice for 20 min. Samples were spun at 13,000 rpm for 20 min, and supernatants were collected. Protein concentrations were determined with the Bio-Rad dye protein assay. The proteins were denatured by heating to 98ЊC for 3 min and then were separated on a 7% SDS-polyacrylamide gel electrophoresis with 4% stacking gel in 1# Tris-glycine buffer (0.025 M Tris, 0.192 M glycine, and 0.1% SDS [pH 8.3]) in a miniprotean cell (Bio-Rad). The separated proteins were electrotransferred onto PVDF membrane with a transfer buffer (25 mM Tris base, 0.2 M glycine, and 20% methanol [pH 8.5]) in a minitransfer cell (Bio-Rad) at 4ЊC for 1 h. Membranes were incubated overnight in blocking buffer containing 1# TBS and 0.1% Tween 20 with 5% dried nonfat milk and then were probed with antifilamin A antibody (Cell Signaling) for 3 h at room temperature. This was followed by incubation with the peroxidase-conjugated secondary anti-rabbit IgG for 1 h at room temperature. Signals were detected by chemoluminescence through use of the Pico Enhanced Chemiluminescence Kit (Pierce Chemical). A prestained molecular-weight ladder (Fermentas) was used to determine protein size.
Immunofluorescence Analyses
Lymphoblasts were obtained from two unaffected subjects and from patient IV-1. Cells were cultured in serum-free RPMI 1640 medium plus 20% FBS (Invitrogen). Cells (∼3,000) were centrifuged with Cytospin Centrifuge for Cells Suspensions (Shandon Cytospin 3 Cytocentrifuge [Global Medical Instrumentation]) at 800 rpm for 3 min and were transferred to the corresponding glass slides. Cells were fixed with 3% paraformaldehyde (Sigma) for 10 min at room temperature. After one wash with 1# PBS (Invitrogen), Triton 0.2% (Bio-Rad) was applied to the slides, which were then incubated at room temperature for 5 min. After another wash with 1# PBS, slides were incubated for 45 min in the dark with phalloidin-Texred (Sigma) (diluted 1:500 in 1# PBS), with mouse antibodies directed to g-tubulin (Sigma) (diluted 1:50 in 1# PBS), or with rabbit antibodies to filamin A (Cell Signalling) (diluted 1:250 in 1# PBS). Fluorochromes can directly bind the phalloidin, which in turn links F-actin, revealing F-actin without antibodies. Secondary anti-mouse and anti-rabbit antibodies (Invitrogen) conjugated to rhodamine were used at concentrations of 1:1000 and 1:200 dilutions, respectively, in 1# PBS. Slides were covered with Mowiol gel (Calbiochem) and then were analyzed by fluorescence microscopy (Laser Scanner Microscopy 510 Zeiss).
Results
Mutation of FLNA in CIIPX
To identify the gene mutated in CIIPX, we analyzed, by reverse transcriptase, the expression pattern of the genes from the CIIPX critical region on Xq28 in c57/BL6 fetal (E18) brain and gut. Of the 63 genes located in the CIIPX critical region, 56 are homologous in mouse and human and therefore were analyzed. We found that 7 of 56 genes are expressed only in intestine, 13 are expressed only in brain, and 28 are expressed in both intestine and brain. Eight genes are not expressed in either tissue but are ex- pressed in lymphoblastoid cell lines (data not shown). We selected seven genes (ZNF275, ATP2B3, DUSP9, SLC6A8, ABCD1, L1CAM, and FLNA) from those expressed in both tissues for direct sequencing analysis of exon and intronexon boundaries. ABCD1, L1CAM, SLC6A8, and FLNA were selected as candidate genes because of their involvement in already-known inherited disorders of the nervous system [7] [8] [9] [10] ; ATP2B3 is a plasma-membrane protein possibly involved in the regulation of physiological ions homeostasis 11 ; DUSP9 was selected because of its protein's interactions with members of the extracellular signal-regulated kinase family of mitogen-activated protein kinases, its possible involvement in regulation of gene expression in neurons of neuroenteric system, and its contribution to pain caused by inflammation 12 ; finally, ZNF275, because of its protein's high similarity to a Zinc-finger protein, was selected as a possible uncharacterized novel putative transcriptional activator. 13 We found that the index patient (IV-1) bears a 2-bp deletion in exon 2 of FLNA (c.65-66delAC). Segregation analysis of the FLNA mutation confirms that all obligate carriers, by pedigree or established by linkage analysis, 4 are heterozygous for the 2-bp deletion (fig. 1B) . The mutation is absent in 164 control X chromosomes.
Recently, a wide spectrum of developmental anomalies has been shown to be caused by mutations in FLNA.
14 Null mutations in the FLNA gene result in bilateral periventricular nodular heterotopia (PVNH [MIM #300049]), an Xlinked dominant neuronal migration disorder clinically characterized by seizures. 15 The association between a potential severe loss-of-function FLNA mutation and an Xlinked recessive disease involving enteric neuron develop- 
ATG Downstream of FLNA c.65-66delAC Allows Production of a Shorter Filamin A Form
The c.65-66delAC deletion found in patients with CIIPX is predicted to cause a frameshift and a premature stop codon at filamin A amino acid position 103 ( fig. 2A) . The predicted mutant protein retains the initial 22 aa identical to wild-type filamin A, followed by 81 different aa before a premature stop codon. This is the most severe FLNA lossof-function mutation described to date, 16 predicted to cause lethality in males and PVNH phenotypes in females. Interestingly, the c.65-66delAC deletion is located 22 codons downstream of the initial FLNA ATG (Met1) ( fig. 2A ) and 5 codons upstream of a second ATG (Met2) ( fig. 2A) . If filamin A translation occurs from either methionine and results in the synthesis of two proteins differing in 27 aa at the NH 2 terminus, the c.65-66delAC deletion would affect only the translation of the longer form of filamin A. To determine whether this is the case, we transiently transfected HEK 293 cells with two different eukaryotic expression plasmids containing the CMV promoter, as shown in figure 2B . In both plasmids, the FLNA-coding sequence from the first methionine to amino acid residue 124 (corresponding to the end of exon 2) was fused to an HA peptide at its 3 end, resulting in peptides of 124 aa of predicted length if translation occurs from Met1 or of 96 aa if it occurs from Met2. Whereas the wild-type FLNA sequence was included in plasmid 1, that bearing the c.65-66delAC deletion was present in plasmid 2. As shown in figure 2C , cells transfected with plasmid 1 express both filamin A forms, whereas those transfected with plasmid 2 express only the shorter form of the protein, albeit at lower levels, possibly because of nonsense-mediated decay. This suggests that (1) filamin A translation can start from either of its two initial methionines, (2) translation of the shorter filamin A form alone occurs because of the c.65-66delAC deletion. To confirm this, we analyzed endogenous filamin A expression in control and patient IV-1 lymphoblasts. Western blot with anti-filamin A antibodies shows that filamin A expression in the patient's lymphoblasts is similar to expression in control lymphoblasts ( fig. 3A) . Although, because of filamin A's high molecular weight (280 kDa), we cannot discriminate whether the protein present in the patient's lymphoblasts is of lower molecular weight than that in control lymphoblasts, these data confirm that c.65-66delAC results in filamin A translation despite the early frameshift. Finally, we investigated the impact of c.65-66delAC on cytoskeletal organization in the patient's lymphoblasts. Whereas actin immunofluorescence staining with phalloidin-Texred is predominantly diffused in the cytoplasm in lymphoblasts from healthy control individuals, in the cells derived from the patient, actin appears mainly concentrated in large dots localized on the centrosome side of the cells ( fig. 4 ; the percentage of cells containing phalloidin dots in patient vs. control lymphoblasts was 78% vs. 9.4%). We con-firmed, by immunofluorescence, the presence of filamin A in the patient's lymphoblasts and that it has a distribution similar to that of actin ( fig. 5) .
We additionally screened a series for but did not find any FLNA mutations in 12 individuals (8 unrelated sporadic and 4 familial cases, 8 males and 4 females, including 1 of the affected males described by FitzPatrick et al. 5 ) affected with isolated non-HSCR CIIPX. In addition, the observed higher penetrance of HSCR in males than in females 17 prompted us to hypothesize that CIIPX might represent an additional susceptibility locus for HSCR. We therefore sequenced the FLNA region containing the two adjacent ATG codons in 37 unrelated patients affected with HSCR (27 males and 10 females), but we did not find any sequence variants.
Discussion
In this article, we show that CIIPX with CNS involvement is associated with a 2-bp deletion in the FLNA gene. This expands the wide spectrum of developmental anomalies caused by FLNA mutations. The FLNA loss-of-function mutations found in PVNH are embryonic lethal in males, 18 although there are reports of males with PVNH who harbor hypomorphic FLNA mutations. 16 FLNA-targeted disruption in mice causes male embryonic lethality, cardiac malformation, and midline skeletal defects. 19 Interestingly, Hehr et al. 20 described a male with PVNH without epilepsy but with severe constipation and facial dysmorphisms who bears an FLNA splice-site mutation resulting in the generation of both normal and aberrant FLNA mRNA. The male patient in our CIIPX-affected family had seizures and potentially has PVNH. Different from the male with PVNH and constipation described by Hehr and colleagues, 20 the CIIPX phenotype in our family is most distinguished by severe CIIP, present at birth, that is lethal unless promptly corrected by surgery.
FLNA encodes for a large cytoskeletal protein (2,639 aa) that cross-links the actin cytoskeleton into orthogonal networks and modulates the cellular response to chemical and mechanical environmental factors by regulating changes in their shape and motility. 21 In mammals, there are three highly homologous filamins: filamin A, B, and C. An actinbinding domain is located at the NH 2 terminus of these proteins and is composed of two calponin homology domains: CH1 and CH2. The remainder of the filamin molecule is composed of 24 filamin repeats that are predicted to adopt structurally homologous b-sheet configurations despite significant divergence at the protein level. 22 The chain of repeats is interrupted by two hinge regions that are proposed to confer flexibility to the Y-shaped filamin dimer. Homodimerization is mediated by the most C-terminal repeat 24 and possibly by other protein domains. We show that, rather than causing a early frameshift, the c.65-66delAC deletion found in the CIIPX-affected patient results in translation of a shorter filamin A from the second ATG. We initially observed this after western blot analysis of lysates from cells transfected with plasmids expressing either the wild-type or the c.65-66delAC cDNA, and we then confirmed the presence of detectable filamin A in the patient's lymphoblasts by both western blot and immunofluorescence analyses. Interestingly, the presence of the mutant filamin A results in peculiar cytoskeletal organization, reflected by a larger amount of phalloidin dots in the patient's than in the control lymphoblasts, which are located on the centrosomal side of the cells. Others have described this large actin dots as "constriction rings." 23 Since cell motility is based on the periodic oscillatory activity of the actin system in association with ring formation and movement across the cell, 23 this ring can contribute to an abnormally polarized cell-surface motility.
This partial FLNA loss of function may explain the recessive CIIPX inheritance in our family. What remains to be elucidated is why this is associated with severe CIIP rather than with a classic PVNH phenotype. In CIIPX, abnormal neurons are present in the myenteric and submucosal plexuses, whereas, in classic PVNH, normally differentiated cortical neurons fail to migrate properly. The association between frameshift and missense heterozygous FLNA mutations with PVNH but not with CIIP may suggest that filamin A dose impacts more severely on cortical neuron migration than on enteric-neuron development. Conversely, since we show that FLNA c.65-66delAC is associated with CIIPX, it is possible that the first 27 FLNA aa residues between Met1 and Met2, adjacent to filamin A actin-binding site 21 and absent in filamin A shorter form, are crucial for proper enteric neuron structure and function.
In conclusion, we show that FLNA c.65-66delAC causes CIIPX with CNS involvement in our family and results in the synthesis of a shorter filamin A form responsible for cytoskeletal abnormalities, which suggests a crucial role for FLNA in enteric-neuron structure and function.
